Higher Degree by Research Candidate
Adelaide Medical School
Faculty of Health and Medical Sciences
I did by Honour project "Role of ABC transporters in high grade serous ovarian cancer progression and chemoresistance." at the University of Adelaide. Now I am a PhD student at the UofA.
PhD: Development of a novel ovarian cancer treatment using CAR-T cells targeting LGR5.
Honour Project: The roles of ABC transporters in ovarian cancer progression and chemoresistance.
Year Citation 2022 Acland, M., Lokman, N. A., Young, C., Anderson, D., Condina, M., Desire, C., . . . Klingler-Hoffmann, M. (2022). Chemoresistant Cancer Cell Lines Are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling Perturbations. Cancers, 14(11), 1-24.
DOI Scopus3 WoS3 Europe PMC3
2022 Leung, D., Price, Z. K., Lokman, N. A., Wang, W., Goonetilleke, L., Kadife, E., . . . Ahmed, N. (2022). Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial–mesenchymal transition interlinked with reprogrammed metabolism. Journal of Translational Medicine, 20(1), 1-23.
DOI Scopus9 WoS7 Europe PMC4
2021 Wang, W., Lokman, N. A., Noye, T. M., Macpherson, A. M., Oehler, M. K., & Ricciardelli, C. (2021). ABCA1 is associated with the development of acquired chemotherapy resistance and predicts poor ovarian cancer outcome. Cancer Drug Resistance, 4(2), 485-502.
DOI Scopus8 WoS8 Europe PMC5
Connect With Me